Featured Research

from universities, journals, and other organizations

Fatigue and excessive daytime sleepiness should be assessed separately in Parkinson’s

Date:
December 1, 2010
Source:
Wiley - Blackwell
Summary:
Nearly three-quarters of patients with Parkinson's disease experience fatigue or excessive daytime sleepiness (EDS). Both have a marked impact on patients' motor functions, everyday activities and quality of life. Researchers who studied 88 outpatients discovered that although fatigue and EDS often co-existed, they were differently associated with severity of motor symptoms, disease duration, depression and dopaminergic (drug) treatment. The research concludes that clinicians should assess both problems separately in order to improve the profession's understanding of their distinct, but overlapping, physiology.

Nearly three-quarters of patients with Parkinson's disease experience fatigue or excessive daytime sleepiness (EDS), but clinicians should assess both problems separately in order to improve the profession's understanding of their distinct, but overlapping, physiology. That is the key finding of a study published in the December issue of the European Journal of Neurology.

Related Articles


Researchers from the University Hospital of Zurich, Switzerland, studied 88 outpatients with Parkinson's. They found that 72% suffered from fatigue or EDS, with just under half of them suffering from both.

"Sleep-wake disturbances such as fatigue and EDS are important non-motor features of Parkinson's" says co-author Dr Christian Baumann. "Their causes remain elusive, but it is possible that multiple factors such as neurodegeneration and medication contribute to them.

"It is important that physicians assess these symptoms, because they have a marked impact on patients' motor functions, everyday activities and quality of life.

"EDS tends to affect up to 50% to 75% of Parkinson's disease patients. This is higher than in other brain disorders such as multiple sclerosis, ischaemic stroke and traumatic brain injury. Fatigue is estimated to affect 40% to 60% of patients with Parkinson's disease, but is often not diagnosed.

"The aim of our study was to systematically assess EDS and fatigue in Parkinson's disease, to determine the overlap between the two symptoms and associate them with other motor and non-motor symptoms and dopaminergic medication."

Eighty-eight consecutive patients aged 38 to 84 attending a movement disorders clinic over a ten-month period were included in the study. Their average age was 67.5 years and 69% were male. Disease duration ranged from two to 28 years, with an average of just under ten years.

Key findings included:

  • 72% of patients suffered from fatigue, EDS or a combination of both. 59% reported fatigue, 24% on its own and 35% with EDS. 48% reported EDS, 13% on its own and 35% with fatigue.
  • Fatigued patients were almost twice as likely to suffer from EDS than non-fatigued patients (60% versus 31%).
  • EDS was more common and severe with longer disease duration, but the same pattern was not observed when it came to fatigue.
  • Fatigued patients with Parkinson's disease had more severe motor symptoms than patients without fatigue. They were also more likely to suffer from Parkinson's-related insomnia than patients without fatigue (77% versus 53%), autonomic disturbances (46% versus 19%) and depression (52% versus 28%).
  • Insomnia was more prevalent in patients with EDS than without (79% versus 57%) but the researchers found no differences when it came to severity of motor symptoms, hallucinations, autonomic disturbances or depression.
  • Increased sleep duration (hypersomnia) was associated with fatigue but not EDS. The 17% of patients who reported increased sleep duration were more likely to be severely affected by motor symptoms than patients with average sleep duration, but did not show an increase in other symptoms.
  • Most of the patients (50%) were receiving a combination of levodopa and a dopamine agonist, 38% were just receiving levodopa and 10% were just receiving a dopamine agonist. No patients were on rasagiline or selegiline.
  • Dopaminergic treatment exerted a stronger influence on EDS than on fatigue. When dopamine agonists were combined with levodopa, this made EDS even worse.

"Our findings suggest that although fatigue and EDS often co-exist in patients with Parkinson's they are differently associated with severity of motor symptoms, disease duration, depression and dopaminergic treatment" concludes Dr Baumann. "For this reason, we feel that fatigue and EDS should be separately assessed in patients with Parkinson's in order to improve our understanding of their distinct but overlapping physiology."


Story Source:

The above story is based on materials provided by Wiley - Blackwell. Note: Materials may be edited for content and length.


Cite This Page:

Wiley - Blackwell. "Fatigue and excessive daytime sleepiness should be assessed separately in Parkinson’s." ScienceDaily. ScienceDaily, 1 December 2010. <www.sciencedaily.com/releases/2010/12/101201095816.htm>.
Wiley - Blackwell. (2010, December 1). Fatigue and excessive daytime sleepiness should be assessed separately in Parkinson’s. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2010/12/101201095816.htm
Wiley - Blackwell. "Fatigue and excessive daytime sleepiness should be assessed separately in Parkinson’s." ScienceDaily. www.sciencedaily.com/releases/2010/12/101201095816.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Rural India's Low-Cost Sanitary Pad Revolution

Rural India's Low-Cost Sanitary Pad Revolution

AFP (Nov. 28, 2014) — One man hopes his invention -– a machine that produces cheap sanitary pads –- will help empower Indian women. Duration: 01:51 Video provided by AFP
Powered by NewsLook.com
Research on Bats Could Help Develop Drugs Against Ebola

Research on Bats Could Help Develop Drugs Against Ebola

AFP (Nov. 28, 2014) — In Africa's only biosafety level 4 laboratory, scientists have been carrying out experiments on bats to understand how virus like Ebola are being transmitted, and how some of them resist to it. Duration: 01:18 Video provided by AFP
Powered by NewsLook.com
WHO Says Male Ebola Survivors Should Abstain From Sex

WHO Says Male Ebola Survivors Should Abstain From Sex

Newsy (Nov. 28, 2014) — WHO cites four studies that say Ebola can still be detected in semen up to 82 days after the onset of symptoms. Video provided by Newsy
Powered by NewsLook.com
Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins